Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Frequency of CPV infection in vaccinated puppies that attended puppy socialization classes.

Stepita ME, Bain MJ, Kass PH.

J Am Anim Hosp Assoc. 2013 Mar-Apr;49(2):95-100. doi: 10.5326/JAAHA-MS-5825. Epub 2013 Jan 16.

PMID:
23325595
2.

Monitoring of canine parvovirus (CPV) strains detected in vaccinated puppies in Brazil.

Castro TX, Costa EM, Leite JP, Labarthe NV, Cubel Garcia RC.

Res Vet Sci. 2011 Apr;90(2):336-40. doi: 10.1016/j.rvsc.2010.06.005. Epub 2010 Jul 6.

PMID:
20609453
3.
4.

Efficacy of vaccination at 4 and 6 weeks in the control of canine parvovirus.

De Cramer KG, Stylianides E, van Vuuren M.

Vet Microbiol. 2011 Apr 21;149(1-2):126-32. doi: 10.1016/j.vetmic.2010.11.004. Epub 2010 Nov 9.

PMID:
21111542
5.

Risk factors for death from canine parvoviral-related disease in Australia.

Ling M, Norris JM, Kelman M, Ward MP.

Vet Microbiol. 2012 Aug 17;158(3-4):280-90. doi: 10.1016/j.vetmic.2012.02.034. Epub 2012 Mar 1.

PMID:
22424864
6.

Canine parvoviruses in New Zealand form a monophyletic group distinct from the viruses circulating in other parts of the world.

Ohneiser SA, Hills SF, Cave NJ, Passmore D, Dunowska M.

Vet Microbiol. 2015 Aug 5;178(3-4):190-200. doi: 10.1016/j.vetmic.2015.05.017. Epub 2015 May 27.

PMID:
26031569
7.

[Canine parvovirus: recent knowledge of the origin and development of a viral pathogen].

Truyen U.

Tierarztl Prax. 1994 Dec;22(6):579-84. Review. German.

PMID:
7716757
8.
9.

Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.

Siedek EM, Schmidt H, Sture GH, Raue R.

Berl Munch Tierarztl Wochenschr. 2011 Jan-Feb;124(1-2):58-64.

PMID:
21306055
10.

Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982-1991).

Houston DM, Ribble CS, Head LL.

J Am Vet Med Assoc. 1996 Feb 15;208(4):542-6.

PMID:
8603904
11.

Vaccination of dogs with Duramune DAPPi+LC protects against pathogenic canine parvovirus type 2c challenge.

Wilson S, Stirling C, Borowski S, Thomas A, King V, Salt J.

Vet Rec. 2013 Jun 22;172(25):662. doi: 10.1136/vr.101509. Epub 2013 Jun 8.

PMID:
23748583
12.

Serum antibody titres to canine parvovirus, adenovirus and distemper virus in dogs in the UK which had not been vaccinated for at least three years.

Böhm M, Thompson H, Weir A, Hasted AM, Maxwell NS, Herrtage ME.

Vet Rec. 2004 Apr 10;154(15):457-63.

PMID:
15119729
14.

Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.

Jacobs AA, Bergman JG, Theelen RP, Jaspers R, Helps JM, Horspool LJ, Paul G.

Vet Rec. 2007 Jan 13;160(2):41-5.

PMID:
17220520
15.
16.

Canine parvovirus types 2c and 2b circulating in North American dogs in 2006 and 2007.

Kapil S, Cooper E, Lamm C, Murray B, Rezabek G, Johnston L 3rd, Campbell G, Johnson B.

J Clin Microbiol. 2007 Dec;45(12):4044-7. Epub 2007 Oct 10.

17.

Early protection of puppies against canine parvovirus: a comparison of two vaccines.

McCaw DL, Tate D, Dubovi EJ, Johnson JC.

J Am Anim Hosp Assoc. 1997 May-Jun;33(3):244-50.

PMID:
9138235
18.
19.

Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b).

Pratelli A, Cavalli A, Normanno G, De Palma MG, Pastorelli G, Martella V, Buonavoglia C.

J Vet Med B Infect Dis Vet Public Health. 2000 May;47(4):273-6.

PMID:
10861195
20.

Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c.

Decaro N, Desario C, Elia G, Martella V, Mari V, Lavazza A, Nardi M, Buonavoglia C.

New Microbiol. 2008 Jan;31(1):125-30.

Supplemental Content

Support Center